Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03747991 · ClinicalTrials.gov registry record
How Reflux Medications Affect the Microbiome of Infants
A clinical trial, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 12
- Enrollment target
NCT03747991 is a clinical trial that has completed, run by Nemours Children's Clinic. The registered enrollment target is 12 participants.
The verdict
NCT03747991 has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The changes in the organisms making up the gut microbiota in infants who are taking anti-acid reflux medications (histamine 2 receptor antagonists) as compared to infants who are not taking these medications is not well-studied or understood. Whether these medications change the gut microbiota and microbiome, and what that change may imply for children on these medications, is the focus of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2019-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03747991
The ClinicalTrials.gov registry entry for NCT03747991 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03747991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03747991 about?
NCT03747991 is a clinical study titled "How Reflux Medications Affect the Microbiome of Infants". The changes in the organisms making up the gut microbiota in infants who are taking anti-acid reflux medications (histamine 2 receptor antagonists) as compared to infants who are not taking these medications is not well-studied or understood. Whether these medications change the gut microbiota and m...
What is the current status of trial NCT03747991?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2018-08-13. Estimated completion is 2019-07-31.
Who is sponsoring clinical trial NCT03747991?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.